BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29399882)

  • 1. Urothelial tumors with villous morphology: Histomorphology and role of immunohistochemistry in diagnosis.
    Mitra S; Chatterjee D; Das A; Gupta K; Radotra BD; Mandal AK
    APMIS; 2018 Mar; 126(3):191-200. PubMed ID: 29399882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
    Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Villous Morphology in Urinary Bladder Biopsy: An Approach to Diagnosis.
    Mitra S; Ayyanar P; Kaur G
    Int J Surg Pathol; 2020 Feb; 28(1):4-12. PubMed ID: 31409167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.
    Bang H; Park H; Park S; Choi E; Cho MS; Sung SH; Choi SY; Cho YM; Jeong SU; Ro JY
    Ann Diagn Pathol; 2020 Feb; 44():151433. PubMed ID: 31785538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma with villoglandular differentiation: a study of 14 cases.
    Lim M; Adsay NV; Grignon D; Osunkoya AO
    Mod Pathol; 2009 Oct; 22(10):1280-6. PubMed ID: 19593329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
    Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
    Downes MR; Torlakovic EE; Aldaoud N; Zlotta AR; Evans AJ; van der Kwast TH
    J Clin Pathol; 2013 Sep; 66(9):779-86. PubMed ID: 23775437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
    Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
    Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
    J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
    Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
    J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
    Irwin T; Donlan AW; Owens L; Alvarez R; Vakar-Lopez F; Tretiakova M
    Hum Pathol; 2024 Apr; 146():43-48. PubMed ID: 38593961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.
    Gulmann C; Paner GP; Parakh RS; Hansel DE; Shen SS; Ro JY; Annaiah C; Lopez-Beltran A; Rao P; Arora K; Cho Y; Herrera-Hernandez L; Alsabeh R; Amin MB
    Hum Pathol; 2013 Feb; 44(2):164-72. PubMed ID: 22995333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
    Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
    Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
    Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S
    Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.